Nilotinib Receives FDA-approval to Treat Pediatric Patients with Chronic Phase CML Approval BlogMedical CommunicationsOncology Updates Nilotinib Receives FDA-approval to Treat Pediatric Patients with Chronic Phase CML
Adcetris is Approved for the Frontline Treatment of stage III or IV Classical Hodgkin Lymphoma in Combination with Chemotherapy Medical CommunicationsOncology Updates Adcetris is Approved for the Frontline Treatment of stage III or IV Classical Hodgkin Lymphoma in Combination with Chemotherapy
Abemaciclib, Another Option for Frontline Treatment of HR-positive Breast Cancer Medical CommunicationsOncology Updates Abemaciclib, Another Option for Frontline Treatment of HR-positive Breast Cancer
Apalutamide, a New Treatment for Nonmetastatic Castration Resistant Prostate Cancer Approval BlogMedical CommunicationsOncology Updates Apalutamide, a New Treatment for Nonmetastatic Castration Resistant Prostate Cancer
Expanded Approval for ZYTIGA® for the Treatment of Castration-sensitive Prostate Cancer Approval BlogMedical CommunicationsOncology Updates Expanded Approval for ZYTIGA® for the Treatment of Castration-sensitive Prostate Cancer
Lutathera®, a New Treatment Option for Patients with Neuroendocrine Tumors Approval BlogMedical CommunicationsOncology Updates Lutathera®, a New Treatment Option for Patients with Neuroendocrine Tumors
Olaparib, the First PARP Inhibitor to Gain FDA Approval to Treat BRCA-mutant Breast Cancer Approval BlogMedical CommunicationsOncology Updates Olaparib, the First PARP Inhibitor to Gain FDA Approval to Treat BRCA-mutant Breast Cancer
Afatinib receives extended approval for frontline treatment of Patients with Non-resistant EGFR Mutation-positive NSCLC Approval BlogMedical CommunicationsOncology Updates Afatinib receives extended approval for frontline treatment of Patients with Non-resistant EGFR Mutation-positive NSCLC
What can the Pharmaceutical industry do to re-prime its development pump? Oncology Updates What can the Pharmaceutical industry do to re-prime its development pump?
Cadence expands its medical communication offerings through KOL Connect®, a comprehensive KOL relationship management solution FEATURED BLOGSFEATURED INSIGHTSMedical CommunicationsOncology Updates Cadence expands its medical communication offerings through KOL Connect®, a comprehensive KOL relationship management solution
